ClinicalTrials.gg
RecruitingNCT06443281Updated May 15, 2026

Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

An observational study in Spinal Cord Injuries, Pain, Neuropathic and Nociceptive Pain, sponsored by University of Zurich. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-15.

Sponsored by University of Zurich · Observational

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
300
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Spinal Cord Injuries by University of Zurich — 7 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · University of Zurich.

Planned enrollment
4th of 10
300 · median 204
Started
2024
with 1 other
Observational
10 of 24
4 open now
Registered
24th of 24
by date

Among the 24 studies in Spinal Cord Injuries by University of Zurich, this one is the 4th largest by planned enrollment of the 10 observational ones that give a count, is one of 2 that started in 2024, is one of 10 observational ones, and was the 24th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

7 of the 24 studies in Spinal Cord Injuries by University of Zurich are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Spinal Cord Injuries by University of Zurich, or all of them as a file.
02

Study summary

The development of neuropathic pain is one of the most debilitating sequels after a spinal cord injury (SCI). The overall aim of this study is to investigate potential underlying pathophysiological mechanisms of neuropathic pain after SCI. The functionality of the nociceptive pathway in humans as well as its plastic changes following SCI will be inferred with sophisticated sensory and pain phenotyping using quantitative sensory testing (i.e., psychophysical measures), objective neurophysiological measures of pain processing and the recording of pain-related autonomic responses (i.e., galvanic skin response, cardiovascular measures and pupil dilation). In addition, the interplay between the somatosensory and autonomic nervous system and its association with the development and maintenance of neuropathic pain after SCI will be investigated.

03

Conditions studied

  • Spinal Cord Injuries
  • Pain, Neuropathic
  • Nociceptive Pain
  • Neuropathy
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

In- and outpatients of Balgrist University Hospital Zurich

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Spinal injury cohort - general inclusion criteria:
  • Aged between 18-80 years
  • Traumatic and non-traumatic etiology
  • Para- and tetraplegic SCI
  • Complete and incomplete SCI
  • SCI with and without neuropathic pain
  • Additional inclusion criteria for longitudinal study:
  • SCI since less than one month
  • Additional inclusion criteria for cross-sectional study:
  • SCI since more than one year
  • Control cohorts with peripheral neuropathy:
  • General inclusion criteria:
  • Aged between 18-80 years
  • Neurological disorder affecting the peripheral nervous system (i.e., peripheral neuropathy)
  • Peripheral neuropathy with or without neuropathic pain
  • Additional inclusion criteria for longitudinal study:
  • Peripheral neuropathy since less than one month
  • Additional inclusion criteria for cross-sectional study:
  • Peripheral neuropathy since more than one year
  • Control cohorts without neuropathy / healthy volunteers
  • General inclusion criteria:
  • Aged between 18-80 years
  • No medical condition affecting the peripheral and/or central nervous system (e.g., pain, systemic disease, psychological disorder)

Exclusion criteria

Exclusion Criteria:

  • Inability to follow study instructions
  • Pregnancy
  • Medically manifested psychological disorder
  • Medical condition affecting the peripheral and/or central nervous system other than the desired experimental condition (e.g., additional peripheral neuropathy in the SCI cohort)
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with spinal cord injury with neuropathic pain

    Diagnostic Test: Neurophysiology · Diagnostic Test: Cardiovascular test · Diagnostic Test: Experimental pain paradigms · Diagnostic Test: Quantitative sensory testing · Diagnostic Test: Clinical pain phenotype · Diagnostic Test: Pupillometry

  • Patients with spinal cord injury but without neuropathic pain

    Diagnostic Test: Neurophysiology · Diagnostic Test: Cardiovascular test · Diagnostic Test: Experimental pain paradigms · Diagnostic Test: Quantitative sensory testing · Diagnostic Test: Pupillometry

  • Patients with peripheral neuropathy

    Diagnostic Test: Neurophysiology · Diagnostic Test: Cardiovascular test · Diagnostic Test: Experimental pain paradigms · Diagnostic Test: Quantitative sensory testing · Diagnostic Test: Clinical pain phenotype · Diagnostic Test: Pupillometry

  • Healthy subjects

    Diagnostic Test: Neurophysiology · Diagnostic Test: Cardiovascular test · Diagnostic Test: Experimental pain paradigms · Diagnostic Test: Quantitative sensory testing · Diagnostic Test: Pupillometry

Interventions

  • Diagnostic testNeurophysiology

    Pain-related evoked potentials and nerve conduction studies

  • Diagnostic testCardiovascular test

    Blood pressure control, orthostatic intolerance test, baro-reflex sensitivity, heart-rate variability

  • Diagnostic testExperimental pain paradigms

    Temporal summation of pain, conditioned pain modulation, offset analgesia

  • Diagnostic testQuantitative sensory testing

    Thermal and mechanical sensory testing

  • Diagnostic testClinical pain phenotype

    Pain drawings, plus and minus signs of pain

  • Diagnostic testPupillometry

    Pupil size changes after phasic and tonic sensory stimulation

06

What researchers measure

Primary outcomes

  1. Spinal cord injury patients: clinical pain phenotype including the spatial pain extent and pain intensity

    Pain drawings, plus and minus signs of pain

    Time frame: Longitudinal: change from 1 month up to 12 months

  2. Spinal cord injury patients: clinical pain phenotype including the spatial pain extent and pain intensity

    Pain drawings, plus and minus signs of pain

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

  3. Patients with peripheral neuropathy: clinical pain phenotype including the spatial pain extent and pain intensity

    Pain drawings, plus and minus signs of pain

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

Secondary outcomes

  1. Spinal cord injury patients / healthy controls: somato-sensory evoked potentials

    Amplitude in uV

    Time frame: Longitudinal: change from 1 month up to 12 months

  2. Spinal cord injury patients / healthy controls: somato-sensory evoked potentials

    Latency in ms

    Time frame: Longitudinal: change from 1 month up to 12 months

  3. Spinal cord injury patients / healthy controls: contact-heat evoked potentials

    Amplitude in uV

    Time frame: Longitudinal: change from 1 month up to 12 months

  4. Spinal cord injury patients / healthy controls: contact-heat evoked potentials

    Latency in ms

    Time frame: Longitudinal: change from 1 month up to 12 months

  5. Spinal cord injury patients / healthy controls: N13 spinal potential

    Amplitude in uV

    Time frame: Longitudinal: change from 1 month up to 12 months

  6. Spinal cord injury patients / healthy controls: N13 spinal potential

    Latency in ms

    Time frame: Longitudinal: change from 1 month up to 12 months

  7. Spinal cord injury patients / healthy controls: motor neurographies

    Amplitude in mV

    Time frame: Longitudinal: change from 1 month up to 12 months

  8. Spinal cord injury patients / healthy controls: motor neurographies

    Latency in ms

    Time frame: Longitudinal: change from 1 month up to 12 months

  9. Spinal cord injury patients / healthy controls: motor neurographies

    Nerve conduction velocity in m/s

    Time frame: Longitudinal: change from 1 month up to 12 months

  10. Spinal cord injury patients / healthy controls: sensory neurography

    Amplitude in mV

    Time frame: Longitudinal: change from 1 month up to 12 months

  11. Spinal cord injury patients / healthy controls: sensory neurography

    Latency in ms

    Time frame: Longitudinal: change from 1 month up to 12 months

  12. Spinal cord injury patients / healthy controls: sensory neurography

    Nerve conduction velocity in m/s

    Time frame: Longitudinal: change from 1 month up to 12 months

  13. Spinal cord injury patients / healthy controls: resting blood pressure

    Systolic, diastolic and mean arterial pressure all in mmHg variability

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

  14. Patients with peripheral neuropathy / healthy controls: changes in blood pressure after a cold pressure test

    Delta mmHg

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

  15. Patients with peripheral neuropathy / healthy controls: changes in blood pressure after a Valsalva maneuvre

    Delta mmHg

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

  16. Patients with peripheral neuropathy / healthy controls: changes in blood pressure after a sit-up test

    Delta mmHg

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

  17. Patients with peripheral neuropathy / healthy controls: baro-reflex sensitivity

    ms/mmHg

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

  18. Patients with peripheral neuropathy / healthy controls: heart rate variability

    RMSSD (root mean square of successive differences), high frequency/low frequency ratio

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

  19. Spinal cord injury patients / healthy controls: temporal summation of pain after repetitive application of 12 pinprick stimuli

    Change in numeric rating scale of pain from the first three to the last three pinprick stimuli

    Time frame: Longitudinal: change from 1 month up to 12 months

  20. Spinal cord injury patients / healthy controls: conditioned pain modulation

    Changes in pressure pain threshold (measured by an algometer in delta kg) before and during a cold water bath

    Time frame: Longitudinal: change from 1 month up to 12 months

  21. Patients with peripheral neuropathy / healthy controls: temporal summation of pain after repetitive application of 12 pinprick stimuli

    Change in numeric rating scale of pain from the first three to the last three pinprick stimuli

    Time frame: Longitudinal: change from 1 month up to 12 months

  22. Patients with peripheral neuropathy / healthy controls: conditioned pain modulation

    Changes in pressure pain threshold (measured by an algometer in delta kg) before and during a cold water bath

    Time frame: Longitudinal: change from 1 month up to 12 months

  23. Spinal cord injury patients / healthy controls: thermal sensory testing tested with a thermode

    Warm detection threshold (°C), cold detection threshold (°C), heat pain threshold (°C), cold pain threshold (°C)

    Time frame: Longitudinal: change from 1 month up to 12 months

  24. Spinal cord injury patients / healthy controls: mechanical sensory testing tested with von Frey monofilaments/pinpricks

    Mechanical detection threshold (mN)

    Time frame: Longitudinal: change from 1 month up to 12 months

  25. Spinal cord injury patients / healthy controls: mechanical sensory testing tested with von Frey monofilaments/pinpricks

    Mechanical pain threshold (mN)

    Time frame: Longitudinal: change from 1 month up to 12 months

  26. Spinal cord injury patients / healthy controls: mechanical sensory testing tested with von Frey monofilaments/pinpricks

    Mechanical pain sensitivity (numeric rating scale of pain 0-10)

    Time frame: Longitudinal: change from 1 month up to 12 months

  27. Spinal cord injury patients / healthy controls: mechanical sensory testing tested with von Frey monofilaments/pinpricks

    Vibration detection threshold (a.u.) tested with Rydel Seiffer tuning fork

    Time frame: Longitudinal: change from 1 month up to 12 months

  28. Patients with peripheral neuropathy / healthy controls: thermal sensory testing tested with a thermode

    Warm detection threshold (°C), cold detection threshold (°C), heat pain threshold (°C), cold pain threshold (°C)

    Time frame: Longitudinal: change from 1 month up to 12 months

  29. Patients with peripheral neuropathy / healthy controls: mechanical sensory testing tested with von Frey monofilaments/pinpricks

    Mechanical detection threshold (mN)

    Time frame: Longitudinal: change from 1 month up to 12 months

  30. Patients with peripheral neuropathy / healthy controls: mechanical sensory testing tested with von Frey monofilaments/pinpricks

    Mechanical pain threshold (mN)

    Time frame: Longitudinal: change from 1 month up to 12 months

  31. Patients with peripheral neuropathy / healthy controls: mechanical sensory testing tested with von Frey monofilaments/pinpricks

    Mechanical pain sensitivity (numeric rating scale of pain 0-10)

    Time frame: Longitudinal: change from 1 month up to 12 months

  32. Patients with peripheral neuropathy / healthy controls: mechanical sensory testing tested with von Frey monofilaments/pinpricks

    Vibration detection threshold (a.u.) tested with Rydel Seiffer tuning fork

    Time frame: Longitudinal: change from 1 month up to 12 months

  33. Spinal cord injury patients / patients with peripheral neuropathy / healthy controls: pupillometry

    Change in pupil size in mm after sensory input (noxious, non-noxious)

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

  34. Spinal cord injury patients / patients with peripheral neuropathy / healthy controls: offset analgesia (psychophysical)

    Change in pain ratings during tonic heat stimulation (offet analgesia paradigm) in numeric rating scale (NRS, scale titel: offset analgesia, 0-100, higher score means better analgesia)

    Time frame: Cross-sectional: once in a chronic stage (1 year post-injury)

  35. Spinal cord injury patients / patients with peripheral neuropathy / healthy controls: offset analgesia (pupillometry)

    Change in pupil size in mm during tonic heat application (offseat analgesia paradigm)

    Time frame: Cross-sectional, once in a chronic stage (1 year post-injury)

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2024 (actual). Primary completion is estimated for Apr 2030, 72 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2024
First posted
Jun 5, 2024
StartActual
Apr 17, 2024
Primary completionEst.
Apr 30, 2030
CompletionEst.
Apr 30, 2030
Last update
May 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06443281
Collaborators
Swiss National Science Foundation
Responsible party
Sponsor
First posted
Jun 5, 2024
Start date
Apr 17, 2024
Primary completion
Apr 30, 2030 (estimated)
Completion
Apr 30, 2030 (estimated)
Last update
May 15, 2026

Study contacts

Michèle Hubli, PD Dr.
Contact
michele.hubli@balgrist.ch
+41 44 510 72 03
Patrick Freund, Prof. Dr. Dr.
principal investigator · University of Zurich

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion